% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • Rob_Cos Rob_Cos Sep 25, 2007 5:14 PM Flag

    CF"Game changing. Not linear-mkt disruptive. SIGNIFANTLY undervalued. $17 tgt!!

    Cantor Fitz-"SGMO Scores - Dow Agro/Mons deal Relies on ZFP. Dow/SGMO tech ahead of schedule and more powerful than anticipated. Game changing. New Industry Std. Not Linear but "Market Disruptive". SIGNIFICANTLY UNDERVALUED. $17 target. BUY"

    Full report:

    Cantor Fitzgerlald
    SEPTEMBER 14, 2007

    Equity Research

    Rating: BUY - Target Price: $17.00

    Sangamo Scores - Dow AgroSciences/Monsanto Collaboration Relies on ZFP Tech

    o As we highlighted in our note last week (Dow AgroSciences Signals Sangamo Alliance Positive Progress- BUY, September 5, 2007), regarding the Sangamo/Dow AgroSciences alliance, the positive progress we anticipated was confirmed today in the conference call following the Dow AgroSciences/Monsanto collaboration announced before the market open this morning.

    o During the call, Dow confirmed that progress involving its collaboration around Sangamo's ZFP technology platform for gene regulation and modification of plants and plant cell cultures � the actionable step toward creating new products after the genes are identified and validated - IS AHEAD OF SCHEDULE AND MORE POWERFUL THAN ANTICIPATED.

    o Both Monsanto and Dow characterize their collaboration, which brings together their respective biotechnology platforms to create the first eight-gene stack offering, branded SmartStax, AS THE NEW INDUSTRY-STANDARD.

    o We think the transformative nature of the integrated DowAgro technology platform � highly reliant on Sangamo's ZFP technology, in our view � positions the company to achieve sustainable top-line and bottom-line growth involving the world's largest and most lucrative markets � food/agro, bioenergy and bioindustrials � that will flow through to Sangamo.

    o We remind investors that technology-driven growth is not linear � it is market-disruptive and we consider the integration of Sangamo's ZFP technology into Dow's platform game-changing. We think SGMO is SIGNIFICANTLY UNDERVALUED and reiterate our BUY rating.

15.54+0.63(+4.23%)Mar 27 4:00 PMEDT